Variant report
Variant | esv3428959 |
---|---|
Chromosome Location | chr2:51487548-51491046 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557107127 | chr2:51487548-51487549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189584778 | chr2:51487559-51487560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149438437 | chr2:51487609-51487610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs553103753 | chr2:51487638-51487639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566283045 | chr2:51487645-51487646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs57393504 | chr2:51487742-51487743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs111525965 | chr2:51487765-51487766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs75642936 | chr2:51487766-51487767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537852732 | chr2:51487774-51487775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555320749 | chr2:51487786-51487787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576640744 | chr2:51487793-51487794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542730151 | chr2:51487848-51487849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs71404995 | chr2:51487878-51487879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181885877 | chr2:51487880-51487881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566026344 | chr2:51487886-51487887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs5831171 | chr2:51487887-51487888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558937359 | chr2:51487972-51487973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141856982 | chr2:51487984-51487985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs373293595 | chr2:51487985-51487986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184784422 | chr2:51487990-51487991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559374295 | chr2:51487991-51487992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529848528 | chr2:51488068-51488069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs144831094 | chr2:51488086-51488087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368711887 | chr2:51488099-51488100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563455992 | chr2:51488156-51488157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140338462 | chr2:51488227-51488228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs57160873 | chr2:51488247-51488248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551474355 | chr2:51488248-51488249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs531526907 | chr2:51488317-51488318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs188361255 | chr2:51488323-51488324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114857125 | chr2:51488339-51488340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571746078 | chr2:51488361-51488362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528068753 | chr2:51488389-51488390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546730181 | chr2:51488401-51488402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568129928 | chr2:51488415-51488416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs13420545 | chr2:51488425-51488426 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs576953629 | chr2:51488448-51488449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs17041489 | chr2:51488459-51488460 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs180672137 | chr2:51488476-51488477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554211022 | chr2:51488482-51488483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs115518020 | chr2:51488542-51488543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558983520 | chr2:51488552-51488553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144153342 | chr2:51488554-51488555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs58610872 | chr2:51488561-51488562 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs541535284 | chr2:51488629-51488630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs574562959 | chr2:51488661-51488662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs375029548 | chr2:51488663-51488664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs17041492 | chr2:51488676-51488677 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs563530762 | chr2:51488698-51488699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7559119 | chr2:51488717-51488718 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Bladder cancer | 21909424 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:51487000-51490600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr2:51489600-51492000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr2:51489800-51491600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr2:51490000-51491800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr2:51490400-51490600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr2:51490400-51491200 | Enhancers | H9 Cell Line | embryonic stem cell |
7 | chr2:51490400-51491800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr2:51490400-51492000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr2:51490400-51492000 | Enhancers | H1 Cell Line | embryonic stem cell |
10 | chr2:51490400-51492000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr2:51490600-51491400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr2:51490600-51492000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr2:51490600-51492000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr2:51490600-51499000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |